PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
01-Nov-2022 Amerigo Scientific Launches New Polyclonal Antibody to Human Blood Coagulation Factor XIII Amerigo Scientific
01-Nov-2022 Creative Diagnostics Introduces Fluorometric Neuraminidase Assay Service for High-throughput Discovery Creative Diagnostics
31-Oct-2022 Preclinical Data Demonstrates SonoTran® Increased Delivery and Efficacy of ADCT-601 in Human Renal Cancer Model OxSonics Therapeutics
28-Oct-2022 dMed | Clinipace announce corporate name change to Caidya ramarketing
28-Oct-2022 Almirall’s Shedding Light on Psoriasis campaign exposes the impact of this disease on the mental health and wellbeing Almirall
27-Oct-2022 ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit ProBioGen
27-Oct-2022 HUTCHMED Initiates a Phase II/III Trial of Fruquintinib in Combination with Sintilimab for Advanced Renal Cell Carcinoma in China HUTCHMED
27-Oct-2022 New US clinical guidelines will recommend Senzime's type of technology for patient monitoring Uppsala
27-Oct-2022 • AmbioPharm to provide cGMP peptide synthesis and support for clinical radiopharmaceutical manufacturing Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership
27-Oct-2022 53% of UK women don’t expect the perimenopause until it happens to them. It’s time for greater awareness, says expert. at London Medical Laboratory,
27-Oct-2022 FUJIFILM Diosynth Biotechnologies Enters Into an Agreement with Argenx to Manufacture Efgartigimod, a monoclonal antibody (mAb) for the Treatment of Severe Autoimmune Diseases FUJIFILM
27-Oct-2022 Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy Santhera and ReveraGen
27-Oct-2022 Crystal Structure Prediction boundaries pushed beyond the pharmaceutical sector to areas such as electronics and photonics Crystal Structure Prediction
27-Oct-2022 Urine could play key part in future biotech systems University of Birmingham
27-Oct-2022 Landmark Nature papers unveil ‘dark matter’ shaping cancer behaviour Landmark Nature
27-Oct-2022 Jazz Pharmaceuticals And Zymeworks Announce Exclusive License Agreement To Develop And Commercialize Zanidatamab, A HER2-Targeted Bispecific Antibody Jazz Pharmaceuticals And Zymeworks
27-Oct-2022 Registration is now open for RNA Therapeutics Conference 2023 SAE Media Group
27-Oct-2022 Co-Chairs from Aerie Pharmaceuticals & Santen Inc USA Invite Industry Experts to join Ophthalmic Drugs SAE Media Group
27-Oct-2022 Brain Implants Market worth US$ 13.3 Billion 2029 with a CAGR of 12.4 % Prophecy Market Insights
27-Oct-2022 Prosthetics Market is estimated to be US$ 9.44 billion by 2030 with a CAGR of 4.5% during the forecast period 2030 Prophecy Market Insights